I beg to differ with all the people who feel that Cardiogenics is not releasing information. The last piece of news was from the US Patent Office on approval of Cardiogenics patent. Read the statement again carefully.

Also read the last 10K, filed with the SEC, where they outlined the steps for the rest of the year. Do you think the first half of the test went bad when they gave this outline.

To refresh everyones memory here is the outline from the 10K:

"Currently, our TnI test product is in the pilot testing phase. Although pilot testing is approximately 50% complete, testing has been suspended until the Company can raise additional funds to cover the remaining costs associated with the pilot testing program. Once the pilot testing is concluded, testing for regulatory approval will be initiated. The filing for U.S. and European regulatory approval is expected before the end of 2015. Upon receipt of FDA approval, we intend to market the QLCA and the Cardiovascular Tests through a major IVD distributor. We have initiated preliminary discussions with several of the Tier 1 IVD companies, and we anticipate that we will commence negotiations with one or more distribution partners before we receive FDA approval . In accordance with industry practice, we intend to enter into a license agreement with our distribution partner for the manufacture and distribution of our products."

Now what more does one need except the announcement of the financing? Does one expect that announcement to come before it is complete?